Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Chromosome Res ; 22(4): 463-81, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25035135

ABSTRACT

Exposure to DNA damaging agents triggers phosphorylation of histone variant H2AX (generating γH2AX) in large chromatin regions flanking DNA lesions, allowing their immunodetection as nuclear foci. Even though a predominance of γH2AX foci in euchromatin has been postulated, foci positioning when DNA insult occurs in replicating eu- or heterochromatin regions has not been extensively explored. Labeling of interphase nuclei with 5-ethynyl-2'-deoxyuridine (EdU) pulses has revealed that DNA replication is temporarily and spatially regulated: euchromatin replicates in early S (ES) and heterochromatin along mid and late S (MS/LS) phases. In order to map DNA damage with respect to replicating domains, the distribution of γH2AX foci induced by the radiomimetic agent bleomycin was analyzed in CHO9 interphase nuclei by delineating euchromatic (H3K4me3+) and replicating (EdU+) regions. Quantification of overlapping pixels and 3D inter-object overlap in binary masks revealed colocalization between γH2AX foci and EdU + domains both in ES and MS/LS nuclei, indicating that primary damage distribution is modulated by DNA synthesis. Further, we verified that EdU incorporation by itself did not influence BLEO-induced γH2AX nuclear patterns. Our results also revealed a repeated localization of γH2AX foci in replicating/nonreplicating interfaces which could reflect short-range chromatin migration following DNA insult.


Subject(s)
Cell Nucleus/genetics , DNA Replication/genetics , Histone Demethylases/genetics , Histones/genetics , Animals , Bleomycin/administration & dosage , CHO Cells , Cell Nucleus/drug effects , Cricetulus , DNA Breaks, Double-Stranded/drug effects , DNA Damage/drug effects , DNA Damage/genetics , DNA Repair/genetics , DNA Replication/drug effects , Euchromatin/drug effects , Euchromatin/genetics , Heterochromatin/drug effects , Heterochromatin/genetics , Interphase/genetics , Phosphorylation
2.
Oncogene ; 26(27): 3963-71, 2007 Jun 07.
Article in English | MEDLINE | ID: mdl-17213813

ABSTRACT

Epigenetic regulation of chromatin structure is central to the process of DNA repair. A well-characterized epigenetic feature is the dynamic phosphorylation of the histone H2AX (gammaH2AX) and mobilization of double strand break (DSB) recognition and repair factors to the site. How chromatin structure is altered in response to DNA damage and how such alterations influence DSB repair mechanisms are currently relevant issues. Despite the clear link between histone deacetylases (HDACs) and radiosensitivity, how histone hyperacetylation influence DSB repair remains poorly understood. We have determined the structure of chromatin is a major factor determining radiosensitivity and repair in human cells. Trichostatin A (TSA) enhances radiosensitivity with dose modification factors of 1.2 and 1.9 at 0.2 and 1 microM, respectively. Cells treated with TSA causing hyperacetylation and remodelling on euchromatic alleles coexist with gammaH2AX accumulation in radiosensitized cells. Formation of gammaH2AX on heterochromatin was significantly reduced even when cells were treated with TSA, suggesting that chromatin structure and histone hyperacetylation are pronounced features of radiation sensitivity and repair in euchromatic regions.


Subject(s)
DNA Damage , DNA Repair/drug effects , Euchromatin/drug effects , Heterochromatin/drug effects , Histone Deacetylase Inhibitors , Hydroxamic Acids/pharmacology , Acetylation/drug effects , Blotting, Western , Caspases/metabolism , Cell Cycle/drug effects , Cell Survival/drug effects , Chromatin Immunoprecipitation , DNA Breaks, Double-Stranded , DNA, Neoplasm/drug effects , DNA, Neoplasm/radiation effects , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Euchromatin/metabolism , Euchromatin/radiation effects , Heterochromatin/metabolism , Heterochromatin/radiation effects , Histone Deacetylases/metabolism , Humans , K562 Cells , Time Factors
3.
J Biomol Struct Dyn ; 35(7): 1491-1499, 2017 May.
Article in English | MEDLINE | ID: mdl-27494525

ABSTRACT

Chelerythrine (CHL), a plant alkaloid, possesses antimicrobial, anti-inflammatory, and antitumor properties. Although CHL influences several key signal transduction pathways, its ability to interact directly with nucleoprotein complex chromatin, in eukaryotic cells has so far not been looked into. Here we have demonstrated its association with hierarchically assembled chromatin components, viz. long chromatin, chromatosome, nucleosome, chromosomal DNA, and histone H3 and the consequent effect on chromatin structure. CHL was found to repress acetylation at H3K9. It is more target-specific in terms of gene expression alteration and less cytotoxic compared to its structural analog sanguinarine.


Subject(s)
Antineoplastic Agents/pharmacology , Benzophenanthridines/pharmacology , Euchromatin/drug effects , Histones/metabolism , Nucleosomes/drug effects , Protein Processing, Post-Translational , Acetylation/drug effects , Cell Survival/drug effects , Chromatin Assembly and Disassembly , DNA/chemistry , DNA/metabolism , Epigenesis, Genetic , Euchromatin/chemistry , Euchromatin/metabolism , HeLa Cells , Histones/genetics , Humans , Isoquinolines/pharmacology , Nucleosomes/chemistry , Nucleosomes/metabolism , Promoter Regions, Genetic
4.
J Interferon Cytokine Res ; 36(1): 37-47, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26418342

ABSTRACT

The genetic regulatory network controlling the innate immune system is well understood in many species. However, the role of the epigenetic mechanisms underlying the expression of immunoregulatory genes is less clear, especially in livestock species. Histone H3 lysine 9 dimethylation (H3K9me2) is an epigenetic modification associated with transcriptional silencing within the euchromatin regions. Euchromatic histone-lysine N-methyltransferase 2 (EHMT2; also known as G9a) is a crucial enzyme responsible for regulating the dynamics of this epigenetic modification. It has been shown that histone modifications play a role in regulating type I interferon (IFN) response. In the present study, we investigated the role of EHMT2 in the epigenetic regulation of bovine antiviral innate immunity and explored its therapeutic potential against viral infections. We evaluated the effects of pharmacological and RNAi-mediated inhibition of EHMT2 on the transcription of IFN-ß and other IFN-inducible antiviral genes, as well as its effect on foot-and-mouth disease virus (FMDV) and vesicular stomatitis virus (VSV) replication in bovine cells. We show that treatment of primary bovine cells with the synthetic EHMT2 inhibitor (UNC0638) either before or shortly after virus infection resulted in a significant increase in transcript levels of bovine IFN-ß (boIFN-ß; 300-fold) and other IFN-inducible genes, including IFN-stimulated gene 15 (ISG-15), myxovirus resistance 1 (Mx-1), Mx-2, RIG-I, 2',5'-oligoadenylate synthetase 1 (OAS-1), and protein kinase R (PKR). Expression of these factors correlated with a significant decrease in VSV and FMDV viral titers. Our data confirm the involvement of EHMT2 in the epigenetic regulation of boIFN-ß and demonstrate the activation of a general antiviral state after EHMT2 inhibition.


Subject(s)
Epigenesis, Genetic , Foot-and-Mouth Disease Virus/drug effects , Histocompatibility Antigens/immunology , Histone-Lysine N-Methyltransferase/immunology , Interferon-beta/immunology , Vesicular stomatitis Indiana virus/drug effects , 2',5'-Oligoadenylate Synthetase/genetics , 2',5'-Oligoadenylate Synthetase/immunology , Animals , Cattle , Cell Line , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/immunology , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/virology , Euchromatin/chemistry , Euchromatin/drug effects , Euchromatin/metabolism , Fetus , Fibroblasts/drug effects , Fibroblasts/immunology , Fibroblasts/virology , Foot-and-Mouth Disease Virus/growth & development , Foot-and-Mouth Disease Virus/immunology , Histocompatibility Antigens/genetics , Histone-Lysine N-Methyltransferase/antagonists & inhibitors , Histone-Lysine N-Methyltransferase/genetics , Immunity, Innate , Interferon-beta/pharmacology , Myxovirus Resistance Proteins/genetics , Myxovirus Resistance Proteins/immunology , Poly I-C/pharmacology , Primary Cell Culture , Quinazolines/pharmacology , RNA, Messenger/genetics , RNA, Messenger/immunology , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Transcription, Genetic , Ubiquitins/genetics , Ubiquitins/immunology , Vesicular stomatitis Indiana virus/growth & development , Vesicular stomatitis Indiana virus/immunology , eIF-2 Kinase/genetics , eIF-2 Kinase/immunology
5.
Biomed Res Int ; 2015: 346134, 2015.
Article in English | MEDLINE | ID: mdl-25961011

ABSTRACT

Stable introduction of a functional gene in hematopoietic progenitor cells (HPCs) has appeared to be an alternative approach to correct genetically linked blood diseases. However, it is still unclear whether lentiviral vector (LV) is subjected to gene silencing in HPCs. Here, we show that LV carrying green fluorescent protein (GFP) reporter gene driven by cytomegalovirus (CMV) promoter was subjected to transgene silencing after transduction into HPCs. This phenomenon was not due to the deletion of proviral copy number. Study using DNA demethylating agent and histone deacetylase (HDAC) inhibitor showed that the drugs could either prevent or reverse the silencing effect. Using sodium bisulfite sequencing and chromatin immunoprecipitation (ChIP) assay, we demonstrated that DNA methylation occurred soon after LV transduction. At the highest level of gene expression, CMV promoter was acetylated and was in a euchromatin state, while GFP reporter gene was acetylated but was strangely in a heterochromatin state. When the expression declined, CMV promoter underwent transition from acetylated and euchromatic state to a heterochromatic state, while the GFP reporter gene was in deacetylated and heterochromatic state. With these, we verify that DNA methylation and dynamic histone modifications lead to transgene silencing in HPCs transduced with LV.


Subject(s)
DNA Methylation/genetics , Hematopoietic Stem Cells , Histone Code/genetics , Histone Deacetylases/biosynthesis , Cytomegalovirus/genetics , DNA Methylation/drug effects , Euchromatin/drug effects , Euchromatin/genetics , Gene Expression Regulation/drug effects , Green Fluorescent Proteins/genetics , Histone Code/drug effects , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/genetics , Humans , Lentivirus/genetics , Promoter Regions, Genetic , Transduction, Genetic , Transgenes/drug effects
6.
Toxicol Sci ; 143(1): 54-63, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25288669

ABSTRACT

Hexavalent chromium is a human respiratory carcinogen that undergoes intracellular activation in vivo primarily via reduction with ascorbate. Replication of Cr-adducted DNA triggers mismatch repair that generates toxic DNA double-strand breaks (DSBs) as secondary lesions. Here, we examined the intranuclear distribution of chromate-induced breaks and a central DSB signaling branch targeting histone H2AX. Using ascorbate-restored cells (H460 human lung epithelial cells, normal human lung and normal mouse embryonic fibroblasts (MEFs)), we found that Cr(VI) produced a typical DSB-associated spectrum of H2AX modifications, including its Ser139-phosphorylated (known as γH2AX) and mono- and diubiquitinated forms. However, whereas canonical DSB signaling relies on ATM, the formation of γH2AX and its ubiquitinated products by Cr(VI) was dependent on ATR kinase. Based on the established mode of ATR activation, this suggests that Cr-induced DSB are not blunt-ended and likely contain single-stranded tails. Confocal imaging with markers of active and inactive chromatin revealed a selective formation of Cr-induced DSB in euchromatin of mouse and human cells. In contrast to DSB, Cr-DNA adducts were produced in both types of chromatin. The euchromatin targeting of Cr-induced DSB makes these lesions particularly dangerous by increasing the probability of deleting active tumor suppressors and producing oncogenic translocations. Accumulation of transcription-inhibiting ubiquitinated forms of γH2AX in euchromatin is expected to contribute to the ability of Cr(VI) to suppress upregulation of inducible genes.


Subject(s)
Cell Nucleus/drug effects , Chromates/toxicity , Chromium/toxicity , DNA Breaks, Double-Stranded , Euchromatin/drug effects , Histones/metabolism , Potassium Compounds/toxicity , Animals , Ascorbic Acid/pharmacology , Ataxia Telangiectasia Mutated Proteins/metabolism , Cell Line, Tumor , Cell Nucleus/enzymology , Cell Nucleus/pathology , Cell Survival/drug effects , Dose-Response Relationship, Drug , Euchromatin/metabolism , Gene Expression Regulation/drug effects , Humans , Mice , Microscopy, Confocal , Oxidation-Reduction , Phosphorylation , Signal Transduction/drug effects , Ubiquitination
7.
Neuro Endocrinol Lett ; 24(5): 329-33, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14647006

ABSTRACT

UNLABELLED: OBJECTIVES and design. We have studied the effect of synthetic peptide Epitalon on the activity of ribosomal genes, denaturation parameters of total heterochromatin, polymorphism of structural C-heterochromatin and the variability of facultative heterochromatin in cultured lymphocytes of persons aged 76-80 years. RESULTS: The obtained data demonstrate that Epitalon induces the activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin and the release of genes repressed due to the age-related condensation of euchromatic chromosome regions. CONCLUSIONS: Epitalon has shown its ability to activate chromatin by modifying heterochromatin and heterochromatinized chromosome regions in the cells of older persons.


Subject(s)
Aging/physiology , Heterochromatin/drug effects , Heterochromatin/genetics , Oligopeptides/pharmacology , Aged , Cells, Cultured , Euchromatin/drug effects , Euchromatin/genetics , Hot Temperature , Humans , Lymphocytes/cytology , Lymphocytes/drug effects , Lymphocytes/physiology , Protein Denaturation , Ribosomal Proteins/genetics , Transcriptional Activation/drug effects
8.
Cell Cycle ; 7(4): 468-76, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18239454

ABSTRACT

The distinction between heterochromatin and euchromatin in the double-strand break (DSB) damage pathway is of interest, recent reports indicate that chromatin is not created equally nor is it acquiescent to DSBs. Using the classical histone deacetylase inhibitor, Trichostatin A, we have previously demonstrated that chromatin represents a heterogeneous substrate with respect to histone tail modification by histone deacetylase inhibitors and consequent responses to DNA damage and repair. Here, we extended the initial findings by investigating the radiation sensitizing properties of the widely used antiepileptic, valproic acid. Clonogenic survival assays confirm that valproic acid is an efficient sensitizer of radiation-induced cell death. The radiosensitizing effect is correlated with valproic acid-mediated histone hyperacetylation, chromatin decondensation and enhanced formation of radiation-induced gammaH2AX preferentially on euchromatic alleles. Heterochromatin was much more resistant to histone tail modification, changes in chromatin architecture and DNA damage. These findings are consolidated by studies with the structurally related analogue, valpromide, which does not inhibit histone deacetylase enzymes. At a relatively low concentration (1 mM) valpromide did not cause chromatin modifications and radiation sensitivity, providing further evidence that the radiation sensitizing properties of valproic acid are at least in part, due to histone modification-dependent effects on euchromatin. When higher concentrations (5 mM) were used, both compounds resulted in significant radiation sensitivity, albeit, with differing efficacy (dose modifying factors of 1.5 and 1.2 for valproic acid and valpromide, respectively). The findings imply that histone-modification independent mechanisms also contribute to the radiation sensitizing properties of valproic acid. Overall, our findings are consistent with the emerging interest in the use histone deacetylase inhibitors in combination with radiotherapy for the treatment of cancer.


Subject(s)
Cell Death/radiation effects , DNA Breaks, Double-Stranded , Euchromatin/drug effects , Heterochromatin/drug effects , Radiation-Sensitizing Agents/pharmacology , Radiotherapy/methods , Valproic Acid/pharmacology , Blotting, Western , Cell Death/drug effects , Cell Line, Tumor , Chromatin Immunoprecipitation , Dose-Response Relationship, Drug , Gamma Rays , Histones/metabolism , Humans , Survival Analysis , Valproic Acid/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL